MRNA:NASDAQModerna, Inc. analysis
Data as of Oct 12, 2026 - not real-time
- Latest price
- $225.00
- Risk: high
- 9/10High risk
Summary
Moderna, Inc. is priced at $225.00 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 57.6%. RSI sits at 72.1, which reads as overbought, and MACD momentum is bearish. Watch $139.02 as support and $225.00 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 45.5% below where the shares trade now. Revenue is growing at 2.1% on a -141.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 80.7%, a beta of 1.99 and a maximum drawdown of 34.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 45.5% below where the shares trade now. Revenue is growing at 2.1% on a -141.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 80.7%, a beta of 1.99 and a maximum drawdown of 34.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top market events
- Second-quarter revenue was USD 145.0 million, up 2.00 percent year over year. Moderna stock costs EU
- Second-quarter revenue reached USD 145.00 million, up 2.00 percent year over year. Moderna stock cos
- Revenue hit USD 145.0 million in the second quarter of 2026. Moderna stock was last at EUR 182.82 ve
Market outlook
Short term
< 1 yearNeutral
Model confidence1/101 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- RSI at 72.1 signals overbought conditions
- Trading above the 200-day average of 72.63
Medium term
1–3 yearsNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- RSI at 72.1 signals overbought conditions
- Trading above the 200-day average of 72.63
Long term
> 3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- Negative profit margin of -141.4%
- Analyst targets imply -45.5% versus the current price
- Negative return on equity of -39.0%
Key metrics
Financial health
Revenue Growth2.10%
Profit Margin-141.43%
P/E Ratio-50.7
ROE-39.00%
ROA-13.26%
Debt/Equity19.04
P/B Ratio13.3
Op. Cash Flow$-1073000000
Free Cash Flow$299.2M
Industry P/E30.5
Technical analysis
TrendBullish
RSI72.1
Support$139.02
Resistance$225.00
MA 20$183.05
MA 50$138.26
MA 200$72.63
MACDBearish
VolumeIncreasing
Fear & Greed Index94.93
Valuation
Fair Value$19.43
Target Price$122.67
Upside/Downside-45.48%
GradeOvervalued
TypeBlend
Risk assessment
Beta1.99
Volatility80.71%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.